Richard Bayliss

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 30

Top Venues

University of Leeds

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Leeds Jan 01 2016

United Kingdom

Prof. of Molecular Medicine :: School of Molecular and Cellular Biology

Publications

Selena G Burgess, Nikki R Paul, Mark W Richards, James R Ault, Laurie Askenatzis, Sophie G Claydon, Ryan Corbyn, Laura M Machesky, Richard Bayliss
A nanobody inhibitor of Fascin-1 actin-bundling activity and filopodia formation. Open biology 14 (3) (2024)
Selena G Burgess, Nikki R Paul, Mark W Richards, James R Ault, Laurie Askenatzis, Sophie G Claydon, Ryan Corbyn, Laura M Machesky, Richard Bayliss
A nanobody inhibitor of Fascin-1 actin-bundling activity and filopodia formation. Open biology 14 (3) (2024)
Raphael Vidal, Eoin Leen, Steffi Herold, Mareike Müller, Daniel Fleischhauer, Christina Schülein-Völk, Dimitrios Papadopoulos, Isabelle Röschert, Leonie Uhl, Carsten Patrick Ade, Peter Gallant, Richard Bayliss, Martin Eilers, Gabriele Büchel
Association with TFIIIC limits MYCN localisation in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA polymerase II. eLife 13 (2024)
Selena G Burgess, Nikki R Paul, Mark W Richards, James R Ault, Laurie Askenatzis, Sophie G Claydon, Ryan Corbyn, Laura M Machesky, Richard Bayliss
A nanobody inhibitor of Fascin-1 actin-bundling activity and filopodia formation. Open biology 14 (3) (2024)
Raphael Vidal, Eoin Leen, Steffi Herold, Mareike Müller, Daniel Fleischhauer, Christina Schülein-Völk, Dimitrios Papadopoulos, Isabelle Röschert, Leonie Uhl, Carsten Patrick Ade, Peter Gallant, Richard Bayliss, Martin Eilers, Gabriele Büchel
Association with TFIIIC limits MYCN localisation in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA polymerase II. eLife 13 (2024)
Raphael Vidal, Eoin Leen, Steffi Herold, Mareike Müller, Daniel Fleischhauer, Christina Schülein-Völk, Dimitrios Papadopoulos, Isabelle Röschert, Leonie Uhl, Carsten Patrick Ade, Peter Gallant, Richard Bayliss, Martin Eilers, Gabriele Büchel
Association with TFIIIC limits MYCN localisation in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA polymerase II. eLife 13 (2024)
Selena G Burgess, Nikki R Paul, Mark W Richards, James R Ault, Laurie Askenatzis, Sophie G Claydon, Ryan Corbyn, Laura M Machesky, Richard Bayliss
A nanobody inhibitor of Fascin-1 actin-bundling activity and filopodia formation. Open biology 14 (3) (2024)
Mariam Elshatlawy, Josephina Sampson, Katy Clarke, Richard Bayliss
EML4-ALK biology and drug resistance in Non-Small Cell Lung Cancer: a new phase of discoveries. Molecular oncology (2023)
Maiara Piovesana, Ana K M Wood, Daniel P Smith, Michael J Deery, Richard Bayliss, Esther Carrera, Nikolaus Wellner, Ondrej Kosik, Johnathan A Napier, Smita Kurup, Michaela C Matthes
A point mutation in the kinase domain of CRK10 leads to xylem vessel collapse and activation of defense responses in Arabidopsis. Journal of experimental botany (2023)
Richard Bayliss, Elżbieta Sarnowska, Sharon Yeoh, Josephina Sampson
ALKing the flames of lung cancer immunosensitivity. Molecular oncology (2023)
Mariam Elshatlawy, Josephina Sampson, Katy Clarke, Richard Bayliss
EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries. Molecular oncology (2023)
Kellie Lucken, Laura O'Regan, Jene Choi, Josephina Sampson, Sarah L Pashley, Richard Bayliss, Sam Khan, Andrew M Fry
EML4-ALK Variant 3 Promotes Mitotic Errors and Spindle Assembly Checkpoint Deficiency Leading to Increased Microtubule Poison Sensitivity. Molecular cancer research : MCR 20 (6) (2022)
Matthew Batchelor, Robert S Dawber, Andrew J Wilson, Richard Bayliss
α-Helix stabilization by co-operative side chain charge-reinforced interactions to phosphoserine in a basic kinase-substrate motif. The Biochemical journal 479 (5) (2022)
Lauren J Tomlinson, Matthew Batchelor, Joscelyn Sarsby, Dominic P Byrne, Philip J Brownridge, Richard Bayliss, Patrick A Eyers, Claire E Eyers
Exploring the Conformational Landscape and Stability of Aurora A Using Ion-Mobility Mass Spectrometry and Molecular Modeling. Journal of the American Society for Mass Spectrometry 33 (3) (2022)
Ellis L Ryan, James Shelford, Teresa Massam-Wu, Richard Bayliss, Stephen J Royle
Defining endogenous TACC3-chTOG-clathrin-GTSE1 interactions at the mitotic spindle using induced relocalization. Journal of cell science 134 (3) (2021)
Adam J Wolpaw, Richard Bayliss, Gabriele Büchel, Chi Van Dang, Martin Eilers, W Clay Gustafson, Gwenn H Hansen, Natalia Jura, Stefan Knapp, Mark A Lemmon, David Levens, John M Maris, Ronen Marmorstein, Steven J Metallo, Julie R Park, Linda Z Penn, Michael Rape, Martine F Roussel, Kevan M Shokat, William P Tansey, Kliment A Verba, Seychelle M Vos, William A Weiss, Elmar Wolf, Yael P Mosse
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers. Cancer research 81 (7) (2021)
Josephina Sampson, Mark W Richards, Jene Choi, Andrew M Fry, Richard Bayliss
Phase-separated foci of EML4-ALK facilitate signalling and depend upon an active kinase conformation. EMBO reports 22 (12) (2021)
Laura O'Regan, Giancarlo Barone, Rozita Adib, Chang Gok Woo, Hui Jeong Jeong, Emily L Richardson, Mark W Richards, Patricia A J Muller, Spencer J Collis, Dean A Fennell, Jene Choi, Richard Bayliss, Andrew M Fry
EML4-ALK V3 oncogenic fusion proteins promote microtubule stabilization and accelerated migration through NEK9 and NEK7. Journal of cell science 133 (9) (2020)
Christopher J Matheson, Christopher R Coxon, Richard Bayliss, Kathy Boxall, Benoit Carbain, Andrew M Fry, Ian R Hardcastle, Suzannah J Harnor, Corine Mas-Droux, David R Newell, Mark W Richards, Mangaleswaran Sivaprakasam, David Turner, Roger J Griffin, Bernard T Golding, Celine Cano
2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase. RSC medicinal chemistry 11 (6) (2020)
Rozita Adib, Jessica M Montgomery, Joseph Atherton, Laura O'Regan, Mark W Richards, Kornelis Straatman, Daniel Roth, Anne Straube, Richard Bayliss, Carolyn A Moores, Andrew M Fry
Mitotic phosphorylation by NEK6 and NEK7 reduces the microtubule affinity of EML4 to promote chromosome congression. Science signaling 12 (594) (2019)
Giampiero Colombano, John J Caldwell, Thomas P Matthews, Chitra Bhatia, Amar Joshi, Tatiana McHardy, Ngai Yi Mok, Yvette Newbatt, Lisa Pickard, Jade Strover, Somaieh Hedayat, Michael I Walton, Stephanie M Myers, Alan M Jones, Harry Saville, Craig McAndrew, Rosemary Burke, Suzanne A Eccles, Faith E Davies, Richard Bayliss, Ian Collins
Binding to an Unusual Inactive Kinase Conformation by Highly Selective Inhibitors of Inositol-Requiring Enzyme 1α Kinase-Endoribonuclease. Journal of medicinal chemistry 62 (5) (2019)
Sharon Yeoh, Richard Bayliss
New tools for evaluating protein tyrosine sulfation and carbohydrate sulfation. The Biochemical journal 475 (19) (2018)
Selena G Burgess, Manjeet Mukherjee, Sarah Sabir, Nimesh Joseph, Cristina Gutiérrez-Caballero, Mark W Richards, Nicolas Huguenin-Dezot, Jason W Chin, Eileen J Kennedy, Mark Pfuhl, Stephen J Royle, Fanni Gergely, Richard Bayliss
Mitotic spindle association of TACC3 requires Aurora-A-dependent stabilization of a cryptic α-helix. The EMBO journal 37 (8) (2018)
Manjeet Mukherjee, Sarah Sabir, Laura O'Regan, Josephina Sampson, Mark W Richards, Nicolas Huguenin-Dezot, James R Ault, Jason W Chin, Anastasia Zhuravleva, Andrew M Fry, Richard Bayliss
Mitotic phosphorylation regulates Hsp72 spindle localization by uncoupling ATP binding from substrate release. Science signaling 11 (543) (2018)
Cory A Ocasio, Alexander A Warkentin, Patrick J McIntyre, Krister J Barkovich, Clare Vesely, John Spencer, Kevan M Shokat, Richard Bayliss
Type II Kinase Inhibitors Targeting Cys-Gatekeeper Kinases Display Orthogonality with Wild Type and Ala/Gly-Gatekeeper Kinases. ACS chemical biology 13 (10) (2018)
Patrick J McIntyre, Patrick M Collins, Lukáš Vrzal, Kristian Birchall, Laurence H Arnold, Chido Mpamhanga, Peter J Coombs, Selena G Burgess, Mark W Richards, Anja Winter, Václav Veverka, Frank von Delft, Andy Merritt, Richard Bayliss
Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches. ACS chemical biology 12 (11) (2017)
Pavithra L Chavali, Lovorka Stojic, Luke W Meredith, Nimesh Joseph, Michael S Nahorski, Thomas J Sanford, Trevor R Sweeney, Benjamin A Krishna, Myra Hosmillo, Andrew E Firth, Richard Bayliss, Carlo L Marcelis, Susan Lindsay, Ian Goodfellow, Christopher Geoffrey Woods, Fanni Gergely
Neurodevelopmental protein Musashi-1 interacts with the Zika genome and promotes viral replication. Science (New York, N.Y.) 357 (6346) (2017)
Selena G Burgess, Arkadiusz Oleksy, Tommaso Cavazza, Mark W Richards, Isabelle Vernos, David Matthews, Richard Bayliss
Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain. Open biology 6 (7) (2017)
Gudrun Bachmann, Mark W Richards, Anja Winter, Fabienne Beuron, Edward Morris, Richard Bayliss
A closed conformation of the Caenorhabditis elegans separase-securin complex. Open biology 6 (4) (2016)
Mark W Richards, Selena G Burgess, Evon Poon, Anne Carstensen, Martin Eilers, Louis Chesler, Richard Bayliss
Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors. Proceedings of the National Academy of Sciences of the United States of America 113 (48) (2016)

Richard Bayliss.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Richard Bayliss